| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.24B | -19.2% | +122.7% |
| Cost of Revenue | $9.22B | -22.4% | +121.8% |
| Gross Profit | $1.02B | +27.6% | +131.4% |
| R&D Expense | $215.7M | +19.3% | +32.4% |
| SG&A Expense | $87.6M | +24.4% | +24.1% |
| Operating Income | $625.9M | +32.0% | +326.4% |
| Pre-tax Income | $611.0M | +22.1% | +431.0% |
| Income Tax | $126.9M | +28.0% | +2071.6% |
| Net Income | $483.4M | +20.7% | +344.4% |
| EPS (Basic) | $0.81 | +20.9% | +350.0% |
| EPS (Diluted) | $0.72 | +20.0% | +323.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.29B | -68.5% | -49.1% |
| Accounts Receivable | $8.41B | -23.5% | +218.4% |
| Inventory | $11.10B | +4.8% | +186.9% |
| Current Assets | $21.57B | -17.4% | +126.7% |
| Total Assets | $23.45B | -16.2% | +118.4% |
| Current Liabilities | $8.12B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.56B | — | — |
| Capital Expenditures | $133.8M | — | — |
| Investing Cash Flow | -$175.8M | — | — |
| Financing Cash Flow | $3.91B | — | — |
| Free Cash Flow | -$7.69B | — | — |
| +468.8% |
| Total Liabilities | $15.88B | -24.4% | +264.2% |
| Stockholders' Equity | $7.58B | +8.3% | +18.7% |